Related Experiment Video
Updated: Jan 23, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Consensus workshops on the development of an ADHD medication management protocol using QbTest: developing a clinical
Charlotte L Hall1, Susan Brown2, Marilyn James3
1Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK. charlotte.hall@nottingham.ac.uk.
Co-developing clinical trial protocols with patients and clinicians enhances feasibility and addresses challenges in randomized controlled trials (RCTs) for Attention Deficit Hyperactivity Disorder (ADHD). This collaborative approach improves participant engagement and outcome relevance.
Area of Science:
- Clinical Research Methodology
- Pediatric Psychiatry
- Health Services Research
Background:
- Randomized controlled trials (RCTs) are crucial but face validity threats like recruitment and adherence issues.
- Involving patients and clinicians in protocol design can mitigate these threats and increase relevance.
- Many protocols lack transparency in their development methodology, hindering knowledge sharing.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Heart Failure V: Medical Management
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management

